These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13313809)

  • 1. Experimental psychotic states.
    MACDONALD JM; GALVIN JA
    Am J Psychiatry; 1956 Jun; 112(12):970-6. PubMed ID: 13313809
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental psychiatry.
    HOCH PH
    Am J Psychiatry; 1955 Apr; 111(10):787-90. PubMed ID: 14361767
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of experimentally induced psychoses on artistic expression.
    TONINI G; MONTANARI C
    Confin Neurol; 1955; 15(4):225-39. PubMed ID: 13305222
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors involved in drug-produced model psychoses.
    FISCHER R
    J Ment Sci; 1954 Jul; 100(420):623-31. PubMed ID: 13192462
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors involved in drug-produced model psychoses.
    FISCHER R
    Experientia; 1954 Oct; 10(10):435-6. PubMed ID: 13220573
    [No Abstract]   [Full Text] [Related]  

  • 6. Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application.
    FABING HD
    Neurology; 1955 May; 5(5):319-28. PubMed ID: 14370384
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental psychiatry. II. Clinical and physio-chemical observations in experimental psychosis.
    RINKEL M; HYDE RW; SOLOMON HC; HOAGLAND H
    Am J Psychiatry; 1955 Jun; 111(12):881-95. PubMed ID: 14376656
    [No Abstract]   [Full Text] [Related]  

  • 8. Model psychoses induced by LSD-25 in normals. II. Rorschach test findings.
    BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):612-8. PubMed ID: 13325990
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental compound mer-17 (frenquel): a new blocking agent against the development of LSD-25 psychosis.
    FABING HD
    Trans Am Neurol Assoc; 1955-1956; (80th Meeting):83-5. PubMed ID: 13312008
    [No Abstract]   [Full Text] [Related]  

  • 10. New blocking agent against the development of LSD-25 psychosis.
    FABING HD
    Science; 1955 Feb; 121(3137):208-10. PubMed ID: 13237971
    [No Abstract]   [Full Text] [Related]  

  • 11. Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction.
    BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):588-611. PubMed ID: 13325989
    [No Abstract]   [Full Text] [Related]  

  • 12. Nicotinic acid modified lysergic acid diethylamide psychosis.
    AGNEW N; HOFFER A
    J Ment Sci; 1955 Jan; 101(422):12-27. PubMed ID: 14368207
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of mescaline, LSD-25, and adrenochrome on depth electrograms in man.
    SCHWARZ BE; SEM-JACOBSEN CW; PETERSEN MC
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):579-87. PubMed ID: 13325988
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lysergic acid ethylamide, a new ergot drug strongly sedative effect causing psychotic states].
    SOLMS H
    Schweiz Med Wochenschr; 1953 Apr; 83(15):356-60. PubMed ID: 13076048
    [No Abstract]   [Full Text] [Related]  

  • 15. [Potentialization of 5-hydroxytryptamine (serotonin) with psychotonic molecules derived from phenylethylamine].
    DELAY J; THULLIER J
    C R Hebd Seances Acad Sci; 1956 Jun; 242(26):3138-40. PubMed ID: 13343594
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined hydrogenated alkaloids of ergot in senile and arteriosclerotic psychoses.
    FORSTER W; SCHULTZ S; HENDERSON AL
    Geriatrics; 1955 Jan; 10(1):26-30. PubMed ID: 13221078
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment by induced psychosis (mescaline and chlorpromazine)].
    POSTEL J; COSSA P
    Ann Med Psychol (Paris); 1956 Jul; 114(2):254-82. PubMed ID: 13340391
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological aspects in schizophrenia research].
    JATZKEWITZ H
    Nervenarzt; 1956 Apr; 27(4):150-2. PubMed ID: 13322144
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental psychiatry. IV. Hallucinogens: tools in experimental psychiatry.
    RINKEL M; HYDE RW; SOLOMON HC
    Dis Nerv Syst; 1955 Aug; 16(8):229-32. PubMed ID: 13241322
    [No Abstract]   [Full Text] [Related]  

  • 20. [First trials of psychopharmacological antagonism; experimental psychoses induced with d-lysergic acid diethylamide and treated with chlorpromazine and reserpine].
    GIBERTI F; GREGORETTI L
    Sist Nerv; 1955; 7(4):301-10. PubMed ID: 13290891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.